Biller LH, Schrag D. Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. JAMA. 2021;325(7):669–85.

Article  CAS  PubMed  Google Scholar 

Biryukov M, Semenov D, Kryachkova N, Polyakova A, Patrakova E, Troitskaya O, Milakhina E, Poletaeva J, Gugin P, Ryabchikova E, Zakrevsky D, Schweigert I, Koval O. The molecular basis for selectivity of the cytotoxic response of lung adenocarcinoma cells to cold atmospheric plasma. Biomolecules. 2023;13(11):1672.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen X, Cubillos-Ruiz JR. Endoplasmic reticulum stress signals in the tumour and its microenvironment. Nat Rev Cancer. 2021;21(2):71–88.

Article  CAS  PubMed  Google Scholar 

Chen B, Zeng X, He Y, Wang X, Liang Z, Liu J, Zhang P, Zhu H, Xu N, Liang S. STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways. Oncotarget. 2016;7(44):71400–16.

Article  PubMed  PubMed Central  Google Scholar 

Cheng H, Wu Z, Wu C, Wang X, Liow SS, Li Z, Wu YL. Overcoming STC2 mediated drug resistance through drug and gene co-delivery by PHB-PDMAEMA cationic polyester in liver cancer cells. Mater Sci Eng C Mater Biol Appl. 2018;83:210–7.

Article  CAS  PubMed  Google Scholar 

Dai Z, Lin B, Qin M, Lin Y, Wang L, Liao K, Xie G, Wang F, Zhang J. METTL3-mediated m6A modification of SLC7A11 enhances nasopharyngeal carcinoma radioresistance by inhibiting ferroptosis. Int J Biol Sci. 2025;21(4):1837–51.

Article  PubMed  PubMed Central  Google Scholar 

DeNicola GM, Karreth FA, Humpton TJ, Gopinathan A, Wei C, Frese K, Mangal D, Yu KH, Yeo CJ, Calhoun ES, Scrimieri F, Winter JM, Hruban RH, Iacobuzio-Donahue C, Kern SE, Blair IA, Tuveson DA. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature. 2011;475(7354):106–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dong S, Zhang M, Cheng Z, Zhang X, Liang W, Li S, Li L, Xu Q, Song S, Liu Z, Yang G, Zhao X, Tao Z, Liang S, Wang K, Zhang G, Hu S. Redistribution of defective mitochondria-mediated dihydroorotate dehydrogenase imparts 5-fluorouracil resistance in colorectal cancer. Redox Biol. 2024;73:103207.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fu NJ, Sheng YW, Fan Z, Wu Z, Li LY, Xi RY, Shi XK, Zhang GL, Wang F. "Synthetic Lethality of SHP2 and XIAP Suppresses Proliferation and Metastasis in KRAS-mutant Nonsmall Cell Lung Cancer." Adv Sci (Weinh) 2025;e2411642.

Gu W, Zhuang W, Zhuang M, He M, Li Z. DNA damage response and repair gene mutations are associated with tumor mutational burden and outcomes to platinum-based chemotherapy/immunotherapy in advanced NSCLC patients. Diagn Pathol. 2023;18(1):119.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang F, Li H, Qin Z, Wang A, Zhang Y, Guo J, Wei M, Guo H, Pu J. SNHG17 Serves as an Oncogenic lncRNA by Regulating the miR-361-3p/STC2 Axis in Rectal Cancer. Front Genet. 2021;12:654686.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang ZH, Shen X, Wei Y, Chen Y, Chai H, Xia L, Leng W. A Pan-Cancer Analysis Reveals the Prognostic and Immunotherapeutic Value of Stanniocalcin-2 (STC2). Front Genet. 2022;13:927046.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Joshi AD. New Insights Into Physiological and Pathophysiological Functions of Stanniocalcin 2. Front Endocrinol (Lausanne). 2020;11:172.

Article  PubMed  Google Scholar 

Kang Z, Li R, Liu C, Dong X, Hu Y, Xu L, Liu X, Xiang Y, Gao L, Si W, Wang L, Li Q, Zhang L, Wang H, Yang X, Liu J. m(6)A-modified cenRNA stabilizes CENPA to ensure centromere integrity in cancer cells. Cell. 2024;187(21):6035-6054.e6027.

Article  CAS  PubMed  Google Scholar 

Kang Q, Hu X, Chen Z, Liang X, Xiang S, Wang Z. The METTL3/TRAP1 axis as a key regulator of 5-fluorouracil chemosensitivity in colorectal cancer. Mol Cell Biochem. 2025;480(3):1865–89.

Article  CAS  PubMed  Google Scholar 

Ke J, Zhang BH, Li YY, Zhong M, Ma W, Xue H, Wen YD, Cai YD. MiR-1-3p suppresses cell proliferation and invasion and targets STC2 in gastric cancer. Eur Rev Med Pharmacol Sci. 2019;23(20):8870–7.

CAS  PubMed  Google Scholar 

Klomp JE, Lee YS, Goodwin CM, Papke B, Klomp JA, Waters AM, Stalnecker CA, DeLiberty JM, Drizyte-Miller K, Yang R, Diehl JN, Yin HH, Pierobon M, Baldelli E, Ryan MB, Li S, Peterson J, Smith AR, Neal JT, McCormick AK, Kuo CJ, Counter CM, Petricoin EF 3rd, Cox AD, Bryant KL, Der CJ. CHK1 protects oncogenic KRAS-expressing cells from DNA damage and is a target for pancreatic cancer treatment. Cell Rep. 2021;37(9):110060.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee YP, Lin CR, Chen SS, Chen RJ, Wu YH, Chen YH, Huang BM. Combination treatment of cordycepin and radiation induces MA-10 mouse Leydig tumor cell death via ROS accumulation and DNA damage. Am J Cancer Res. 2023;13(4):1329–46.

CAS  PubMed  PubMed Central  Google Scholar 

Li S, Wang L, Wang Y, Zhang C, Hong Z, Han Z. The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment. J Hematol Oncol. 2022b;15(1):147.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li M, Xia M, Zhang Z, Tan Y, Li E, Guo Z, Fang M, Zhu Y, Hu Z. METTL3 antagonizes 5‑FU chemotherapy and confers drug resistance in colorectal carcinoma. Int J Oncol 2022;61(3).

Lin C, Sun L, Huang S, Weng X, Wu Z. STC2 Is a Potential Prognostic Biomarker for Pancreatic Cancer and Promotes Migration and Invasion by Inducing Epithelial-Mesenchymal Transition. Biomed Res Int. 2019;2019:8042489.

Article  PubMed  PubMed Central  Google Scholar 

Lin Y, Li J, Liang S, Chen Y, Li Y, Cun Y, Tian L, Zhou Y, Chen Y, Chu J, Chen H, Luo Q, Zheng R, Wang G, Liang H, Cui P, An S. Pan-cancer Analysis Reveals m6A Variation and Cell-specific Regulatory Network in Different Cancer Types. Genomics Proteomics Bioinformatics 2024;22(4).

Mamontova V, Trifault B, Gribling-Burrer AS, Bohn P, Boten L, Preckwinkel P, Gallant P, Solvie D, Ade CP, Papadopoulos D, Eilers M, Gutschner T, Smyth RP, Burger K. NEAT1 promotes genome stability via m(6)A methylation-dependent regulation of CHD4. Genes Dev. 2024;38(17–20):915–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mauri G, Patelli G, Crisafulli G, Siena S, Bardelli A. Tumor “age” in early-onset colorectal cancer. Cell. 2025;188(3):589–93.

Article  CAS  PubMed  Google Scholar 

McDaid WJ, Wilson L, Adderley H, Martinez-Lopez A, Baker MJ, Searle J, Ginn L, Budden T, Aldea M, Marinello A, Aredo JV, Viros A, Besse B, Wakelee HA, Blackhall F, Castillo-Lluva S, Lindsay CR, Malliri A. The PI3K-AKT-mTOR axis persists as a therapeutic dependency in KRAS(G12D)-driven non-small cell lung cancer. Mol Cancer. 2024;23(1):253.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moser JC, Papadopoulos KP, Ahnert JR, Ofir-Rosenfeld Y, Holz JB. Phase 1 dose escalation and cohort expansion study evaluating safety, PK, PD and clinical activity of STC-15, a METTL-3 inhibitor, in patients with advanced malignancies. J Clin Oncol. 2024;42(16_suppl):2586–2586.

Article  Google Scholar 

Murray CE, Kornepati AVR, Ontiveros C, Liao Y, de la Peña Avalos B, Rogers CM, Liu Z, Deng Y, Bai H, Kari S, Padron AS, Boyd JT, Reyes R, Clark CA, Svatek RS, Li R, Hu Y, Wang M, Conejo-Garcia JR, Byers LA, Ramkumar K, Sood AK, Lee JM, Burd CE, Vadlamudi RK, Gupta HB, Zhao W, Dray E, Sung P, Curiel TJ. Tumour-intrinsic PDL1 signals regulate the Chk2 DNA damage response in cancer cells and mediate resistance to Chk1 inhibitors. Mol Cancer. 2024;23(1):242.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pan J, Liu F, Xiao X, Xu R, Dai L, Zhu M, Xu H, Xu Y, Zhao A, Zhou W, Dang Y, Ji G. METTL3 promotes colorectal carcinoma progression by regulating the m6A-CRB3-Hippo axis. J Exp Clin Cancer Res. 2022;41(1):19.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Panagal M, RSS, SP, BM, KM, Gopinathe V, Sivakumare P, Sekar D. MicroRNA21 and the various types of myeloid leukemia. Cancer Gene Ther 2018;25(7-8): 161-166.

Qi YN, Liu Z, Hong LL, Li P, Ling ZQ. Methyltransferase-like proteins in cancer biology and potential therapeutic targeting. J Hematol Oncol. 2023;16(1):89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qian S, Liu J, Liao W, Wang F. METTL3 promotes non-small-cell lung cancer growth and metastasis by inhibiting FDX1 through copper death-associated pri-miR-21-5p maturation. Epigenomics. 2023;15(23):1237–55.

Article  CAS